CAR T cells chimeric antigen receptor cells

BIOLOGICAL3 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China, King Faisal Specialist Hospital & Research Center, N.N. Alexandrov National Cancer Centre

Conditions

Relapsed Refractory Acute Lymphoblastic LeukemiaRelapsed/Refractory B-Cell NeoplasmsSystem Lupus Erythematosus(SLE)

Phase 1

A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms

Not yet recruitingNCT07200479

Institute of Hematology & Blood Diseases Hospital, ChinaRelapsed/Refractory B-Cell Neoplasms

Start: 2025-10-30End: 2027-12-30Target: 20Updated: 2025-10-01

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

RecruitingNCT07361029

King Faisal Specialist Hospital & Research CenterRelapsed Refractory Acute Lymphoblastic Leukemia

Start: 2025-07-29End: 2028-07-01Target: 24Updated: 2026-01-22

Unknown Phase

Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus

Enrolling by invitationNCT07720310

N.N. Alexandrov National Cancer CentreSystem Lupus Erythematosus(SLE)

Start: 2026-03-09End: 2030-06-01Target: 12Updated: 2026-07-22